Share
Bayesian Designs for Phase I-Ii Clinical Trials (Chapman & Hall
Ying Yuan; Hoang Q. Nguyen; Peter F. Thall (Author)
·
Crc Pr Inc
· Paperback
Bayesian Designs for Phase I-Ii Clinical Trials (Chapman & Hall - Ying Yuan; Hoang Q. Nguyen; Peter F. Thall
£ 35.99
£ 39.99
You save: £ 4.00
Choose the list to add your product or create one New List
✓ Product added successfully to the Wishlist.
Go to My WishlistsIt will be shipped from our warehouse between
Monday, June 10 and
Thursday, June 13.
You will receive it anywhere in United Kingdom between 1 and 3 business days after shipment.
Synopsis "Bayesian Designs for Phase I-Ii Clinical Trials (Chapman & Hall"
Reliably optimizing a new treatment in humans is a critical first step in clinical evaluation since choosing a suboptimal dose or schedule may lead to failure in later trials. At the same time, if promising preclinical results do not translate into a real treatment advance, it is important to determine this quickly and terminate the clinical evaluation process to avoid wasting resources. Bayesian Designs for Phase I-II Clinical Trials describes how phase I-II designs can serve as a bridge or protective barrier between preclinical studies and large confirmatory clinical trials. It illustrates many of the severe drawbacks with conventional methods used for early-phase clinical trials and presents numerous Bayesian designs for human clinical trials of new experimental treatment regimes.Written by research leaders from the University of Texas MD Anderson Cancer Center, this book shows how Bayesian designs for early-phase clinical trials can explore, refine, and optimize new experimental treatments. It emphasizes the importance of basing decisions on both efficacy and toxicity.
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
All books in our catalog are Original.
The book is written in English.
The binding of this edition is Paperback.
✓ Producto agregado correctamente al carro, Ir a Pagar.
